Jinhe Biotechnology CO., LTD. (002688.SZ)

3.7000 +0.0900 (+2.49%) At close: 03:04PM CST

Jinhe Biotechnology CO., LTD.

1-7-2 Building 27
Zone B3 Xinghai Plaza Shahekou District
Dalian 116023
China

https://www.jinhe.com.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2,316

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Changxian Xie	GM & Director	N/A	N/A	1962
Mr. You Shan Niu	Financial Director	N/A	N/A	1971
Mr. Zhi Jun Wang	Deputy GM & Director	N/A	N/A	1974
Mr. Manman Lu	Board Secretary & Director	N/A	N/A	1973
Mr. Zhi Sheng Wang	Deputy General Manager	N/A	N/A	1962
Mr. Ying Chun Liu	Deputy General Manager	N/A	N/A	1967
Ms. Yueqing Wang	Deputy GM & Non-Independent Director	N/A	N/A	1974

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD. was founded in 1990 and is based in Dalian, China.

Corporate governance

Jinhe Biotechnology CO., LTD.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.